<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30690483</article-id>
<article-id pub-id-type="pmc">6548221</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddz019</article-id>
<article-id pub-id-type="publisher-id">ddz019</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>General Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>UBE3A regulates the transcription of IRF, an antiviral immunity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Furumai</surname>
<given-names>Ryohei</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tamada</surname>
<given-names>Kota</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Xiaoxi</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0001-7153-266X</contrib-id>
<name>
<surname>Takumi</surname>
<given-names>Toru</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1"></xref>
<!--<email>toru.takumi@riken.jp</email>-->
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>RIKEN Brain Science Institute, Wako, Saitama, Japan</aff>
<aff id="aff2"><label>2</label>Graduate School of Biomedical Sciences, Hiroshima University, Minami, Hiroshima, Japan</aff>
<author-notes>
<corresp id="cor1">To whom correspondence should be addressed at: RIKEN Center for Brain Science, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Tel: +81 484675906; Fax: +81 484676079; Email: <email>toru.takumi@riken.jp</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-01-26" pub-type="epub">
<day>26</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>6</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>28</volume>
<issue>12</issue>
<fpage>1947</fpage>
<lpage>1958</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>10</day>
<month>1</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>1</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ddz019.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>
<italic>UBE3A</italic> is a gene responsible for the pathogenesis of Angelman syndrome (AS), a neurodevelopmental disorder characterized by symptoms such as intellectual disability, delayed development and severe speech impairment. <italic>UBE3A</italic> encodes an E3 ubiquitin ligase, for which several targets have been identified, including synaptic molecules. Although proteolysis mainly occurs in the cytoplasm, UBE3A is localized to the cytoplasm and the nucleus. In fact, UBE3A is also known as a transcriptional regulator of the family of nuclear receptors. However, the function of UBE3A in the nucleus remains unclear. Therefore, we examined the involvement of UBE3A in transcription in the nuclei of neurons. Genome-wide transcriptome analysis revealed an enrichment of genes downstream of interferon regulatory factor (IRF) in a <italic>UBE3A</italic>-deficient AS mouse model. <italic>In vitro</italic> biochemical analyses further demonstrated that UBE3A interacted with IRF and, more importantly, that UBE3A enhanced IRF-dependent transcription. These results suggest a function for UBE3A as a transcriptional regulator of the immune system in the brain. These findings also provide informative molecular insights into the function of UBE3A in the brain and in AS pathogenesis.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Takeda Science Foundation</named-content>
<named-content content-type="funder-identifier">10.13039/100007449</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Japan Science and Technology Agency</named-content>
<named-content content-type="funder-identifier">10.13039/501100002241</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Center of Neurology and Psychiatry</named-content>
<named-content content-type="funder-identifier">10.13039/501100009438</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Mental Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000025</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Core Research for Evolutional Science and Technology</named-content>
<named-content content-type="funder-identifier">10.13039/501100003382</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Japan Society of Promotion of Science and Ministry of Education, Culture, Sports, Science and Technology</named-content>
</funding-source>
<award-id>16H06463</award-id>
<award-id>16H06316</award-id>
<award-id>15K08305</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="12"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>